Emerging Onychomycosis therapies including BB2603 (Blueberry Therapeutics), VT-1161 (Mycovia Pharmaceuticals), KERYDIN (tavaborole), JUBLIA/CLENAFIN (efinaconazole), and others are driving market size. DelveInsight’s “Onychomycosis Market Insights, Epidemiology, and Market Forecast – 2034”
Onychomycosis Market Size Expected to Witness Significant Growth by 2034, estimates DelveInsight
DelveInsight’s “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the
DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone
DelveInsight’s “Neuroblastoma Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Neuroblastoma pipeline landscape. It covers the Neuroblastoma Pipeline drug profiles, including clinical
DelveInsight’s, “Sjogren’s Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Sjogren’s Syndrome
DelveInsight’s, “HER2 Positive Breast Cancer Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in
The Chronic Refractory Gout (CRG) Market is growing due to the rising prevalence of chronic gout, uncontrolled hyperuricemia, and increasing
The Non-Cystic Fibrosis Bronchiectasis (NCFB) Market is growing due to the rising prevalence of chronic respiratory diseases, improved diagnosis through
The Invasive Fungal Infections (IFIs) Market is growing due to the rising incidence of opportunistic fungal infections in immunocompromised patients,
Key Autism Spectrum Disorder companies such as Otsuka Pharmaceutical, Johnson & Johnson, Flynn Pharma, Aardvark Therapeutics, Inc., H. Lundbeck A/S,
